🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment

RecruitingNAAges 18 Years - anyAllAssistance Publique - Hôpitaux de Paris
NCT06858527 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders (SUDs) is a highly common comorbid condition associated with serious medical and psychosocial consequences. However, and despite the international consensus recommending integrated treatment for this comorbidity, few studies tested the efficacy of specific psychotherapeutic treatment for this comorbidity. The aim of this study is to test the efficacy of a specific group Cognitive and Behavioral Therapy (CBT) for the treatment of adults with this comorbidity. This is a longitudinal, randomized controlled intervention study utilizing a crossover design between the intervention and treatment-as-usual (TAU) waitlist condition, aimed at testing the effectiveness of an integrated psychotherapeutic group treatment for adults with comorbid Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders (SUD

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 or older ; * Suffer from at least one moderate to severe SUD regarding the DSM-5 (tobacco excluded) ; * Being currently treated for a SUD by a physician of a psychologist ; * Being diagnosed with an ADHD according to the DIVA 2.0 of DIVA-5 ; * Being affiliated to a health insurance ; * Understanding and being able to express himselves in French * Signed consent Exclusion Criteria: * Age under 18; * Pregnant or breastfeeding women; * Not having sign the consent form; * Major difficulties in understanding and/or expressing themselves in french; * Severe cognitive impairment; * Acute medical condition making assessment impossible and/or contraindicating participation in group intervention; * Substance use disorder in a protected environment, currentlu or in the last 15 days, or expected during the study; * No substance use disorder other than tobacco use disorder; * Persons under guardianship; * Participant deprived of liberty or under penal care orders; * Participation in another group psychotherapeutic intervention throughout the duration of the intervention
💊

What it tests

  • TAU+integrated group CBT
📍

Where

1 site
Hôpital Fernand Widal, Assistance-Publique - Hôpitaux de Paris
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy